ZNF503 and central nervous system cancer: To further understand the function of ZNF503-AS2 in tumor immunity, we classified glioma samples based on ZNF503-AS2 expression, immune cells, and immune function gene sets and identified two immune typing patterns, which were labeled Cluster 1 and Cluster 2 (Fig 3I).